|
ABOS
|
Acumen Pharmaceuticals, Inc.
|
US
|
NASDAQ
|
|
ADAG
|
Adagene Inc.
|
US
|
NASDAQ
|
|
ADAP
|
Adaptimmune Therapeutics plc
|
US
|
NASDAQ
|
|
ADTX
|
ADiTx Therapeutics, Inc.
|
US
|
NASDAQ
|
|
ALBT
|
Avalon GloboCare Corp.
|
US
|
NASDAQ
|
|
ALPN
|
Alpine Immune Sciences, Inc.
|
US
|
NASDAQ
|
|
APTO
|
Aptose Biosciences, Inc.
|
US
|
NASDAQ
|
|
ARDS
|
Aridis Pharmaceuticals Inc.
|
US
|
NASDAQ
|
|
ARGX
|
argenx SE
|
US
|
NASDAQ
|
|
ATNM
|
Actinium Pharmaceuticals, Inc.
|
US
|
AMEX
|
|
BCTX
|
BriaCell Therapeutics Corp.
|
US
|
NASDAQ
|
|
BLCM
|
Bellicum Pharmaceuticals, Inc.
|
US
|
NASDAQ
|
|
CADL
|
Candel Therapeutics, Inc.
|
US
|
NASDAQ
|
|
CDMO
|
Avid Bioservices, Inc.
|
US
|
NASDAQ
|
|
CDTX
|
Cidara Therapeutics, Inc.
|
US
|
NASDAQ
|
|
CLDX
|
Celldex Therapeutics, Inc.
|
US
|
NASDAQ
|
|
CNCR
|
Loncar Cancer Immunotherapy ETF
|
US
|
NASDAQ
|
|
CNTA
|
Centessa Pharmaceuticals plc
|
US
|
NASDAQ
|
|
CNTB
|
Connect Biopharma Holdings Limited
|
US
|
NASDAQ
|
|
CVM
|
Cel-Sci Corporation
|
US
|
AMEX
|